References
- Kommuru TR, Gurley B, Khan MA, Reddy IK. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int J Pharm 2001;212:233–246
- Mohsin K, Alanazi F. The fate of paclitaxel during in vitro dispersion testing of different lipid-based formulations. J Drug Deliv Sci Technol 2012;22:197–204
- Mohsin K, Pouton CW. The influence of the ratio of lipid to surfactant and the presence of cosolvent on phase behaviour during aqueous dilution of lipid-based drug delivery systems. J Drug Del Sci Technol 2012;22:531–540
- Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and ‘self-microemulsifying’ drug delivery systems. Eur J Pharm Sci 2000;11:S93–S98
- Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004;58:173–182
- Mohsin K, Long MA, Pouton CW. Design of lipid-based formulations for oral administration of poorly water-soluble drugs: precipitation of drug after dispersion of formulations in aqueous solution. J Pharm Sci 2009;98:3582–3595
- Charman WN, Rogge MC, Boddy AW, Berger BM. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J Clin Pharmacol 1993;33:381–386
- Mueller EA, Kovarik JM, van Bree JB, et al. Improved dose linearity of cyclosporine pharmacokinetics from a microemulsion formulation. Pharm Res 1994;11:301–304
- Atef E, Belmonte AA. Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS). Eur J Pharm Sci 2008;35:257–263
- Pouton CW. Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification. Int J Pharm 1985;27:335–348
- Pouton CW, Porter CJ. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 2008;60:625–637
- Vonderscher J, Meinzer A. Rationale for the development of Sandimmune Neoral. Transplant Proc 1994;26:2925–2927
- Fatouros DG, Karpf DM, Nielsen FS, Mullertz A. Clinical studies with oral lipid based formulations of poorly soluble compounds. Ther Clin Risk Manag 2007;3:591–604
- Loftsson T, Hreinsdóttir D, Másson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm 2005;302:18–28
- Kossena GA, Charman WN, Boyd BJ, et al. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach. J Pharm Sci 2004;93:332–348
- Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci 2006;29:278–287
- Al-Amri KA, Mohsin K, Alanazi FK. Development and validation of a UPLC method for quantification of antiviral agent, acyclovir in lipid-based formulations. Arab J Chem 2014
- Kang BK, Lee JS, Chon SK, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 2004;274:65–73
- Craig DQM, Barker SA, Banning D, Booth SW. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm 1995;114:103–110
- Shahba AA, Mohsin K, Alanazi FK. The studies of phase equilibria and efficiency assessment for self-emulsifying lipid-based formulations. AAPS PharmSciTech 2012;13:522–533
- Baka E, Comer JEA, Takács-Novák K. Study of equilibrium solubility measurement by saturation shake-flask method using hydrochlorothiazide as model compound. J Pharm Biomed Anal 2008;46:335–341
- Devraj R, Williams HD, Warren DB, et al. In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine. Eur J Pharm Sci 2013;49:748–760
- FDA. Guidance for Industry: Bioanalytical Method Validation. Rockville, MD, USA: US Dept. of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM); 2001
- Shah NH, Carvajal MT, Patel CI, et al. Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm 1994;106:15–23
- Shahba AA, Mohsin K, Alanazi FK. Novel self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of cinnarizine: design, optimization, and in-vitro assessment. AAPS PharmSciTech 2012;13:967–977
- Tao Y, Lu Y, Sun Y, et al. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability. Int J Pharm 2009;378:30–36
- Tavakoli N, Varshosaz J, Dorkoosh F, et al. Development and evaluation of a monolithic floating drug delivery system for acyclovir. Chem Pharm Bull (Tokyo) 2012;60:172–177
- Arnal J, Gonzalez-Alvarez I, Bermejo M, et al. Biowaiver monographs for immediate release solid oral dosage forms: aciclovir. J Pharm Sci 2008;97:5061–5073
- Shojaei AH, Berner B, Xiaoling L. Transbuccal delivery of acyclovir: I. in vitro determination of routes of buccal transport. Pharm Res 1998;15:1182–1188
- Gu CH, Rao D, Gandhi RB, et al. Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility. J Pharm Sci 2005;94:199–208